Andrea S. Blevins Primeau, PhD, MBA

Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.

Most Recent Articles by Andrea S. Blevins Primeau, PhD, MBA

In Focus: Blinatumomab for Non-Hodgkin Lymphoma

In Focus: Blinatumomab for Non-Hodgkin Lymphoma

By

Although blinatumomab shows promising antitumor activity among patients with varying subtypes of NHL, the incidence of neurologic toxicity is high.

Midostaurin Plus Chemotherapy Prolongs Survival in AML With FTL3 Mutation

Midostaurin Plus Chemotherapy Prolongs Survival in AML With FTL3 Mutation

By

Adding midostaurin — a multi-targeted kinase inhibitor — to chemotherapy prolongs overall survival (OS) among patients with newly diagnosed AML and an FLT3 mutation.

First-line Nivolumab Fails To Prolong Survival in Stage IV NSCLC

First-line Nivolumab Fails To Prolong Survival in Stage IV NSCLC

By

Study results suggest that first-line treatment of advanced NSCLC with nivolumab does not prolong PFS or OS compared with chemotherapy, though nivolumab had a better safety profile.

Phase 3 Vadastuximab Talirine Trials Halted Due to Deaths

Phase 3 Vadastuximab Talirine Trials Halted Due to Deaths

By

The data showed a higher rate of death, including fatal infections, in the vadastuximab talirine arm compared with the chemotherapy-only arm.

Potential Drug- and Herb-Drug Interactions Among Patients With Cancer

Potential Drug- and Herb-Drug Interactions Among Patients With Cancer

By

Drug-drug and herb-drug interactions are common among patients with cancer and can have important clinical ramifications.

More Articles by Andrea S. Blevins Primeau, PhD, MBA

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters